TRIUMFNews - Page 1

TRIUMF and actinium-225 – the ‘world’s rarest drug’

By developing isotopes like actinium-225, the research and development teams at TRIUMF have the potential to revolutionise cancer care.

Celebrating 50 years of beam at TRIUMF

TRIUMF reflects on five decades of discovery since the world’s largest cyclotron was activated at the centre.

Canadian contributions shine bright in high-luminosity upgrades to Large Hadron Collider

TRIUMF outlines Canada’s contribution to the crucial upgrades of CERN’s Large Hadron Collider and a new era of particle physics research.

Canadian Government invests $399.8m into TRIUMF particle accelerator centre

The Canadian Government unveiled an unprecedented investment of $399.8m in funding for TRIUMF, Canada's esteemed particle accelerator centre.

Two flagship research facilities set to accelerate Canadian leadership in global Big Science

TRIUMF, Canada’s particle accelerator centre, is putting Canada on the Big Science global stage.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd